Drs. Analía Mykietiuk and María Fernanda Alzogaray, along with the entire Clinical Research team at the Platense Medical Institute, were recognized for their work with the César Milstein Award in the category of “Health Personnel or Health Institution Committed to Innovation.”
The awarding of this mention is linked to the performance of Grupo Sur in the clinical study to test the immunogenicity of the ARVAC – Cecilia Grierson vaccine.
The aim of this award is to raise awareness of the importance of cooperation, effective communication, and multidisciplinary collaboration, as well as to highlight the need for public policies that promote research and technological development to provide concrete solutions to society.
We are happy to share with you this news that is a great encouragement to continue developing our work day by day.
Today, more than ever, we renew our commitment: more science means more health for everyone.
